These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 12135278)

  • 1. Short report: absence of protective neutralizng antibodies to West Nile virus in subjects following vaccination with Japanese encephalitis or dengue vaccines.
    Kanesa-Thasan N; Putnak JR; Mangiafico JA; Saluzzo JE; Ludwig GV
    Am J Trop Med Hyg; 2002 Feb; 66(2):115-6. PubMed ID: 12135278
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A plant-produced vaccine protects mice against lethal West Nile virus infection without enhancing Zika or dengue virus infectivity.
    Lai H; Paul AM; Sun H; He J; Yang M; Bai F; Chen Q
    Vaccine; 2018 Mar; 36(14):1846-1852. PubMed ID: 29490880
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vero cell-derived inactivated West Nile (WN) vaccine induces protective immunity against lethal WN virus infection in mice and shows a facilitated neutralizing antibody response in mice previously immunized with Japanese encephalitis vaccine.
    Lim CK; Takasaki T; Kotaki A; Kurane I
    Virology; 2008 Apr; 374(1):60-70. PubMed ID: 18221765
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vaccines Against Dengue and West Nile Viruses in India: The Need of the Hour.
    Gore MM
    Viral Immunol; 2020; 33(6):423-433. PubMed ID: 32320353
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecularly engineered live-attenuated chimeric West Nile/dengue virus vaccines protect rhesus monkeys from West Nile virus.
    Pletnev AG; Claire MS; Elkins R; Speicher J; Murphy BR; Chanock RM
    Virology; 2003 Sep; 314(1):190-5. PubMed ID: 14517072
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chimeric dengue 2 PDK-53/West Nile NY99 viruses retain the phenotypic attenuation markers of the candidate PDK-53 vaccine virus and protect mice against lethal challenge with West Nile virus.
    Huang CY; Silengo SJ; Whiteman MC; Kinney RM
    J Virol; 2005 Jun; 79(12):7300-10. PubMed ID: 15919884
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of the protective ability of plasma from Japanese individuals against mosquito-borne viral infections.
    Shinohara N; Owada T; Matsumoto C; Uchida S; Nagai T; Satake M; Tadokoro K
    Trans R Soc Trop Med Hyg; 2017 Sep; 111(9):393-401. PubMed ID: 29294131
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Non-structural protein 1 (NS1) antibody-based assays to differentiate West Nile (WN) virus from Japanese encephalitis virus infections in horses: effects of WN virus NS1 antibodies induced by inactivated WN vaccine.
    Kitai Y; Kondo T; Konishi E
    J Virol Methods; 2011 Jan; 171(1):123-8. PubMed ID: 20974180
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human antibody response to immunization with 17D yellow fever and inactivated TBE vaccine.
    Kayser M; Klein H; Paasch I; Pilaski J; Blenk H; Heeg K
    J Med Virol; 1985 Sep; 17(1):35-45. PubMed ID: 2995571
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prospects for development of a vaccine against the West Nile virus.
    Monath TP
    Ann N Y Acad Sci; 2001 Dec; 951():1-12. PubMed ID: 11797767
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The suitability of yellow fever and Japanese encephalitis vaccines for immunization against West Nile virus.
    Yamshchikov G; Borisevich V; Kwok CW; Nistler R; Kohlmeier J; Seregin A; Chaporgina E; Benedict S; Yamshchikov V
    Vaccine; 2005 Sep; 23(39):4785-92. PubMed ID: 15939510
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The efficacy of inactivated West Nile vaccine (WN-VAX) in mice and monkeys.
    Muraki Y; Fujita T; Matsuura M; Fuke I; Manabe S; Ishikawa T; Okuno Y; Morita K
    Virol J; 2015 Apr; 12():54. PubMed ID: 25889682
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Japanese encephalitis vaccine-facilitated dengue virus infection-enhancement antibody in adults.
    Saito Y; Moi ML; Takeshita N; Lim CK; Shiba H; Hosono K; Saijo M; Kurane I; Takasaki T
    BMC Infect Dis; 2016 Oct; 16(1):578. PubMed ID: 27756212
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibody responses induced by experimental West Nile virus infection with or without previous immunization with inactivated Japanese encephalitis vaccine in horses.
    Shirafuji H; Kanehira K; Kamio T; Kubo M; Shibahara T; Konishi M; Murakami K; Nakamura Y; Yamanaka T; Kondo T; Matsumura T; Muranaka M; Katayama Y
    J Vet Med Sci; 2009 Jul; 71(7):969-74. PubMed ID: 19652487
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Infectivity of West Nile/dengue chimeric viruses for West Nile and dengue mosquito vectors.
    Hanley KA; Goddard LB; Gilmore LE; Scott TW; Speicher J; Murphy BR; Pletnev AG
    Vector Borne Zoonotic Dis; 2005; 5(1):1-10. PubMed ID: 15815144
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Formalin-inactivated whole virus and recombinant subunit flavivirus vaccines.
    Eckels KH; Putnak R
    Adv Virus Res; 2003; 61():395-418. PubMed ID: 14714438
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antigenic comparison of envelope protein E between Japanese encephalitis virus and some other flaviviruses using monoclonal antibodies.
    Kimura-Kuroda J; Yasui K
    J Gen Virol; 1986 Dec; 67 ( Pt 12)():2663-72. PubMed ID: 2432163
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The immunogenicity of tetravalent dengue DNA vaccine in mice pre-exposed to Japanese encephalitis or Dengue virus antigens.
    Prompetchara E; Ketloy C; Keelapang P; Sittisombut N; Ruxrungtham K
    Asian Pac J Allergy Immunol; 2015 Sep; 33(3):182-8. PubMed ID: 26342114
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An inactivated cell culture Japanese encephalitis vaccine (JE-ADVAX) formulated with delta inulin adjuvant provides robust heterologous protection against West Nile encephalitis via cross-protective memory B cells and neutralizing antibody.
    Petrovsky N; Larena M; Siddharthan V; Prow NA; Hall RA; Lobigs M; Morrey J
    J Virol; 2013 Sep; 87(18):10324-33. PubMed ID: 23864620
    [TBL] [Abstract][Full Text] [Related]  

  • 20. West Nile virus infection and serologic response among persons previously vaccinated against yellow fever and Japanese encephalitis viruses.
    Johnson BW; Kosoy O; Martin DA; Noga AJ; Russell BJ; Johnson AA; Petersen LR
    Vector Borne Zoonotic Dis; 2005; 5(2):137-45. PubMed ID: 16011430
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.